Infertility

Friday, February 21, 2014
08:30-10:00
Industry Symposium

10:20-11:50 Industry Symposium 

12:10-13:40
EVIDENCE VERSUS ART IN ART
Supported by an unrestricted grant from Merck-Serono
Capsule

Evidence based medicine is a goal but can it always be applied in ART?

Chairperson Gab Kovacs, Australia
Debate: Science vs ART: The use or lack of evidence based medicine in ART
Pro Science: Basing treatments on evidence
Natasha Andreadis, Australia

PRO Art: ART does not lends itself to evidence only …..
Michele Kwik
, Australia

Discussion
Debate: Day 5 or Day 3 transfer
Proposition: All transfers should be blastocyst
Simone Campbell, Australia
Opposition: Transfer should be at day 3
William S.B. Yeung, Hong Kong
14:30-16:00
LUTEAL PHASE SUPPORT IN INFERTILITY
Capsule
The controversy around luteal phase support – when should we support, with what and for how long – continues. While there is no doubt the need to support the luteal phase with progestogens in infertility treatments, the question remains: for how long? The role of progestogens in recurrent miscarriage is even more complex and is based on expert opinion rather than on level 1 proof
Role of progestogens in early pregnancy
Adolf E. Schindler, Germany
Which progestogen? When and what dose so as to optimise Luteal support in IVF/ICSI cycles
Mark Brincat, Malta
Recurrent pregnancy loss: What do we know and what can we do?
Bruce Young, USA
Is acupuncture useful in assisted reproduction?
Ernest H.Y. Ng, Hong Kong

16:30-18:00
DECREASED OVARIAN RESERVE
Capsule
DOR is a frustrating condition which is associated with lower success rate and very little variation of the response to treatment
Chairperson Marie-Madeleine Dolmans, Belgium
Simone Campbell, Australia
New criteria for diagnosis
Luca Gianaroli, Italy
Debate: Can we improve response by increasing the dose of Menotropins?
Yes: higher dose can stimulate oocytes which need higher FSH threshold
Stratis Kolibianakis, Greece
No: the differences are not dependent on the dose but it is the cycle to cycle variation in response that counts
Salim Daya, Canada
Discussion
Use of additions for poor responders: Letrozole, DHEA, androgens and growth hormone
Ernest H.Y. Ng, Hong Kong

Saturday, February 22, 2014
08:30-10:00
OVARIAN STIMULATION
Capsule
It seems odd, but simple questions such as the intensity of stimulation or no stimulation for IVF are still controversial
Chairpersons Jie Qiao, China
Raoul Orvieto, Israel
IVF and risk of thrombosis
Alexandr Makatsariya
, Russia
Epigenetic aspects of assisted reproduction
Hefeng Huang, China
Debate: Ovarian Stimulation or slight stimulation? Is low intensity ("mild" or "mini") ovarian stimulation preferable?
Yes: Zi-Jiang Chen, China
No:
Nicolas Zech, Austria
Discussion

10:20-11:50
FERTILITY PRESERVATION
Capsule Is Cryopreservation of gametes and ovaries to preserve fertility of cancer patients should be deemed experimental or established procedure?
Chairpersons Marie-Madeleine Dolmans, Belgium
Yael Gonen, Israel
Vitrification of oocytes: Advances and progress
Ri-Cheng Chian, Canada
Cryopreservation and reimplantation of ovarian tissue: Who are the candidates? Results and techniques
Jacques Donnez, Belgium
Is it a real risk to re-implant malignant cells? When?
Marie-Madeleine Dolmans, Belgium
Vitrification for non-medical reasons: Social and professional perspectives
Oriol Coll, Spain

12:10-13:40
IMPROVING IMPLANTATION RATE
Capsule Implantation is the least effective step in the whole IVF procedure. How can we improve it?
Chairpersons P.C. Ho, Hong Kong
Michele Kwik, Australia
Yanwen Xu, China
Should we be doing all our embryo transfers under ultrasound guidance?
Gab Kovacs, Australia
Ovarian stimulation and endometrial receptivity
P.C. Ho, Hong Kong
Treating thin endometrium, resistant to standard modalities
Raoul Orvieto, Israel
Uterine septum: should we operate on all patients or only following pregnancy failure?
Jacques Donnez, Belgium

14:30-16:00
IMPROVING RESULTS IN IVF and MALE FACTOR INFERTILITY
Capsule
For some time, it appeared that ICSI had put to rest most of the male infertility evaluation processes and treatments. Nonetheless, the jury is still out on this issue. Can evaluation and treatment of male infertility before IVF ensure a better destiny for future generations? Does IMSI (intracytoplasmic morphologically selected sperm injection) improve IVF results and outcomes beyond ICSI, thus making the extra investment cost-effective in cases of poor sperm quality?
Chairpersons Salim Daya, Canada
Gab Kovacs
, Australia
Debate: IMSI Is there any scientific evidence of its value?
Yes: N.  Zech, Austria
No: ICSI provides similar results
Salim Daya, Canada
Discussion
Advanced male age: Effect on perinatal outcome
Joseph Schenker, Israel

16:30-17:30
TREATMENTS OF PCOS PATIENTS
Capsule
The controversy over the management of Polycystic Ovarian Syndrome (PCOS) continues. The debate here is on the best way in which to achieve a pregnancy in PCOS patients while minimizing risks. Mild stimulation IVF, IVM, ovarian drilling or GnRH to trigger ovulation: what direction, if any, is preferable? Different points of view – any winner?
Chairpersons Zion Ben Rafael, Israel
Gab Kovach, Australia
Debate: Prevention OHSS one or many strategies?
IVM for PCOS patients
Jie Qiao, China
Mild stimulation in PCOS patients will decrease OHSS without compromising the result of treatment
Salim Daya, Canada
GnRH-a to trigger ovulation should be used in all PCOS patients to prevent OHSS
Stratis Kolibianakis, Greece
Discussion

17:30-18:15
LOW COST IVF
Capsule
IVF is an expensive procedure with a modest success rate. Even in the most affluent countries, the population is under-served partly because of the high cost involved. Certainly the cost can be reduced, and needs to be reduced, especially in nations with lower resources. The entire procedure can be made more affordable by limiting the diagnostic test, monitoring and cost of stimulation and using cheaper stimulation. The question is to what extent can this be carried out without affecting results or increasing risks?
Chairpersons Zion Ben Rafael, Israel
Gab Kovacs, Australia
Debate: This house believes that the cost of IVF can be reduced substantially without compromising safety or increasing the risks
Proposition: The cost of preparation for treatment, monitoring and stimulation can be reduced without compromising the results or increasing the risk
Gab Kovacs
, Australia
Opposition: Minimal monitoring and cheaper stimulation may affect results and increase the risk
Salim Daya, Canada
Discussion

Sunday, February 23, 2014
08:00-12:45
Uterine Transplantation Workshop
HOW TO ESTABLISH A SUCCESSFUL UTERINE TRANSPLANTATION CLINIC
For the program please link here

 

Join COGI now

Deadline for Online Registration

February 17, 2014

Secure your Spot for the
Uterine Transplantation Workshop

Scientific Information

Scientific Program

Registration & Accommodation

Sponsorship & Exhibition